Angiotensin receptor blockers (ARBs) vs. angiotensin-converting enzyme inhibitors (ACEi) treatment in hypertension: what is the evidence to date? Part 1

Angiotensin receptor blockers (ARBs) vs. angiotensin-converting enzyme inhibitors (ACEi) treatment in hypertension: what is the evidence to date? In this first part, Professor Williams explores why ARBs and ACEi are the foundation of antihypertensive therapy before going on to compare the relative merits of each approach to blocking the RAS system.
Login/ Register Maximise Minimise